Read: All MSF updates on COVID-19
~

Kyrgyzstan

The prevalence of drug-resistant tuberculosis (DR-TB) in Kyrgyzstan, one of the poorest nations in the Central Asian region, remains very high.

 

Kyrgyzstan has an inadequate healthcare system, experiencing frequent shortages, and today, many people struggle to access free treatment for DR-TB.

The rates of drug resistance among new TB cases are as high as one third, and in previously treated TB cases, more than half of patients have developed the drug resistant form of the disease.

We provide outpatient care for people with DR-TB, thereby limiting the time they have to spend in hospital. Patients attend monthly medical consultations at one of three TB clinics supported by us, and include psychological support.

IN 2018:

0
OUTPATIENT CONSULTATIONS
0
ANTENATAL CONSULTATIONS
0
PEOPLE STARTED ON TREATMENT FOR DR-TB

1996

YEAR MSF FIRST WORKED IN THE COUNTRY
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons